Topical Immuonosuppressant Drugs in Spring Catarrh
Status:
Not yet recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
Spring catarrh is a prevalent type of conjunctival allergic disorder in temperate countries.
Topical steroids are the cornerstone management of spring catarrh beside other anti allergic
drugs. However, prolonged use of topical steroids especqially in resistant spring catarrh
carries risk of ocular side effects as 2nd glaucoma and cataract. We will investigate the
safety and efficacy of topical immuonosuppressant in the management of resistant spring
catarrh as an alternative to steroid therapy.